• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病中的全身炎症:急性加重的作用。

Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations.

作者信息

Wouters Emiel F M, Groenewegen Karin H, Dentener Mieke A, Vernooy Juanita H J

机构信息

Department of Respiratory Medicine, University Hospital Maastricht, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.

出版信息

Proc Am Thorac Soc. 2007 Dec;4(8):626-34. doi: 10.1513/pats.200706-071TH.

DOI:10.1513/pats.200706-071TH
PMID:18073394
Abstract

The systemic manifestations of chronic obstructive pulmonary disease (COPD) exacerbations are recognized, but our understanding of their etiology and importance is lacking largely due to the small number of systematic and longitudinal studies. Most of the systemic manifestations are likely the result of inflammatory processes. Serum biomarkers, such as various cytokines, adipokines, C-reactive protein, and coagulation factors, are elevated during exacerbations. Our understanding of the systemic manifestations can be greatly enhanced if we integrate what is known about the basic science of systemic mediators with the translational science of their role in COPD exacerbations. Many overlapping connections and promising avenues of future research come to light with such a viewpoint.

摘要

慢性阻塞性肺疾病(COPD)急性加重的全身表现已得到公认,但由于系统性和纵向研究数量较少,我们对其病因及重要性的了解仍很欠缺。大多数全身表现可能是炎症过程的结果。在急性加重期间,血清生物标志物如各种细胞因子、脂肪因子、C反应蛋白和凝血因子会升高。如果我们将关于全身介质基础科学的已知知识与它们在COPD急性加重中作用的转化科学相结合,就能大大增进我们对全身表现的理解。从这样的观点来看,许多重叠的联系和未来研究的有前景途径便会显现出来。

相似文献

1
Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations.慢性阻塞性肺疾病中的全身炎症:急性加重的作用。
Proc Am Thorac Soc. 2007 Dec;4(8):626-34. doi: 10.1513/pats.200706-071TH.
2
Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers.慢性阻塞性肺疾病急性加重期患者血浆瘦素和脂联素水平:与炎症生物标志物的相关性。
Respir Med. 2010 Jan;104(1):40-6. doi: 10.1016/j.rmed.2009.08.012. Epub 2009 Sep 25.
3
Local and systemic inflammation in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中的局部和全身炎症
Proc Am Thorac Soc. 2005;2(1):26-33. doi: 10.1513/pats.200408-039MS.
4
Dysregulated adipokine metabolism in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中脂肪因子代谢失调。
Eur J Clin Invest. 2012 Sep;42(9):983-91. doi: 10.1111/j.1365-2362.2012.02686.x. Epub 2012 Jun 15.
5
Gender differences in the adipose secretome system in chronic obstructive pulmonary disease (COPD): a pivotal role of leptin.慢性阻塞性肺疾病(COPD)脂肪分泌系统中的性别差异:瘦素的关键作用。
Respir Med. 2011 Jul;105(7):1046-53. doi: 10.1016/j.rmed.2011.02.001. Epub 2011 Mar 1.
6
Predictors of chronic obstructive pulmonary disease exacerbations.慢性阻塞性肺疾病急性加重的预测因素。
Curr Opin Pulm Med. 2014 Mar;20(2):138-45. doi: 10.1097/MCP.0000000000000031.
7
[Role of endothelial dysfunction, the interface between hemostatic and system inflammatory responses in the pathogenesis of an infectious inflammation-dependent exacerbation of chronic obstructive pulmonary disease].[内皮功能障碍的作用,即止血与全身炎症反应之间的界面在慢性阻塞性肺疾病感染性炎症依赖性加重发病机制中的作用]
Ter Arkh. 2013;85(3):17-22.
8
[Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].[轻度至中度慢性阻塞性肺疾病急性加重期全身炎症的病因及生物标志物]
Rev Med Chil. 2012 Jan;140(1):10-8. Epub 2012 Apr 12.
9
Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病新细菌菌株加重的炎症特征
Am J Respir Crit Care Med. 2008 Mar 1;177(5):491-7. doi: 10.1164/rccm.200708-1234OC. Epub 2007 Dec 13.
10
Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients.稳定期 COPD 患者的动态性肺过度充气与低度系统性炎症。
Eur Rev Med Pharmacol Sci. 2011 Sep;15(9):1068-73.

引用本文的文献

1
SCGB1A1 as a Key Regulator of Splenic Immune Dysfunction in COPD: Insights From a Murine Model.SCGB1A1作为慢性阻塞性肺疾病脾脏免疫功能障碍的关键调节因子:来自小鼠模型的见解
Int J Chron Obstruct Pulmon Dis. 2025 Mar 3;20:497-509. doi: 10.2147/COPD.S506332. eCollection 2025.
2
Is 'Cardiopulmonary' the New 'Cardiometabolic'? Making a Case for Systems Change in COPD.“心肺”会成为新的“心脏代谢”吗?为慢性阻塞性肺疾病的系统变革提供依据。
Pulm Ther. 2024 Dec;10(4):363-376. doi: 10.1007/s41030-024-00270-2. Epub 2024 Sep 9.
3
Multi-center Korean cohort study based on RNA-sequencing data targeting COPD patients.
基于 RNA 测序数据的针对 COPD 患者的多中心韩国队列研究。
Sci Data. 2024 Jun 6;11(1):593. doi: 10.1038/s41597-024-03389-8.
4
Elucidating the risk of cardiopulmonary consequences of an exacerbation of COPD: results of the EXACOS-CV study in Germany.阐明 COPD 加重的心肺后果风险:德国 EXACOS-CV 研究的结果。
BMJ Open Respir Res. 2024 Mar 30;11(1):e002153. doi: 10.1136/bmjresp-2023-002153.
5
Heightened long-term cardiovascular risks after exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重后长期心血管风险增加。
Heart. 2024 Apr 25;110(10):702-709. doi: 10.1136/heartjnl-2023-323487.
6
Auditory function assessment in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的听觉功能评估
SAGE Open Med. 2023 Dec 1;11:20503121231216212. doi: 10.1177/20503121231216212. eCollection 2023.
7
Incident low muscle mass is associated with greater lung disease and lower circulating leptin in a tobacco-exposed longitudinal cohort.在一个暴露于烟草的纵向队列中,事件性低肌肉质量与更严重的肺部疾病和循环瘦素水平降低相关。
Respir Res. 2023 Sep 22;24(1):224. doi: 10.1186/s12931-023-02521-3.
8
Prevalence, predictors, dynamic bone change, and treatment efficacy of osteoporosis among chronic obstructive pulmonary disease patients: a prospective cohort study.慢性阻塞性肺疾病患者骨质疏松症的患病率、预测因素、动态骨变化及治疗效果:一项前瞻性队列研究
Front Med (Lausanne). 2023 Aug 8;10:1214277. doi: 10.3389/fmed.2023.1214277. eCollection 2023.
9
11β-HSD1 determines the extent of muscle atrophy in a model of acute exacerbation of COPD.11β-HSD1 决定 COPD 急性加重模型中肌肉萎缩的程度。
Am J Physiol Lung Cell Mol Physiol. 2023 Apr 1;324(4):L400-L412. doi: 10.1152/ajplung.00009.2022. Epub 2023 Feb 21.
10
All-cause admissions following a first ever exacerbation-related hospitalisation in COPD.慢性阻塞性肺疾病(COPD)首次因病情加重住院后的全因住院情况。
ERJ Open Res. 2023 Jan 3;9(1). doi: 10.1183/23120541.00217-2022. eCollection 2023 Jan.